SCHEMBL7609387

SCHEMBL7609387

CCOC(=O)COc1ccc(C(CN(Cc2ccccc2)CC(O)c2ccc(OCc3ccccc3)c(NS(C)(=O)=O)c2)c2ccc(OCC(=O)OCC)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 10/20 0.45
NR3C1 P04150 3/20 0.41
AR P10275 2/20 0.41
PGR P06401 1/20 0.41
NR3C2 P08235 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.38
ADRB2 P07550 2/20 0.38
KCNH2 Q12809 1/20 0.38
ALDH1A1 P00352 1/20 0.37
NPC1 O15118 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ESRRA P11474 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7608253 1.00 ADRB3 (0.45) ADRB3NR3C1ARPGRNR3C2
SCHEMBL7611523 0.86 L3MBTL1 (0.41) ADRB3L3MBTL1ADRB2ALDH1A1NPC1
SCHEMBL7608285 0.85 ADRB3 (0.40) ADRB3NR3C1ARPGRNR3C2
SCHEMBL7609423 0.85 ADRB3 (0.40) ADRB3NR3C1ARPGRNR3C2
SCHEMBL7656679 0.84 ADRB3 (0.44) ADRB3ADRB2
SCHEMBL6074837 0.84 ADRB3 (0.50) ADRB3NR3C1ADRB2
SCHEMBL7606877 0.84 ADRB3 (0.44) ADRB3NR3C1ARPGRNR3C2
SCHEMBL7608520 0.83 FFAR1 (0.40) L3MBTL1ALDH1A1HPGDSMN1; SMN2
SCHEMBL7605273 0.82 ADRB3 (0.44) ADRB3ADRB2KCNH2
SCHEMBL7610055 0.80 ADRB3 (0.40) ADRB3NR3C1ARADRB2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1230210-A1 AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-08-14 EP disclosed
WO-2001036375-A1 AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-05-25 WO disclosed